Cargando…
Measuring Value in the Treatment of Symptoms of Allergic Rhinitis With Nasal Steroids
Patients' willingness to pay (WTP) is a subject of interest, particularly in these times of consumer-directed health care and benefit designs that involve multiple copayment tiers. Since tiered copayment products have been found to reduce premium costs, the continued proliferation of tiered cop...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437939/ https://www.ncbi.nlm.nih.gov/pubmed/16515376 http://dx.doi.org/10.18553/jmcp.2006.12.2.168 |
_version_ | 1785092654375108608 |
---|---|
author | Curtiss, Frederic R. |
author_facet | Curtiss, Frederic R. |
author_sort | Curtiss, Frederic R. |
collection | PubMed |
description | Patients' willingness to pay (WTP) is a subject of interest, particularly in these times of consumer-directed health care and benefit designs that involve multiple copayment tiers. Since tiered copayment products have been found to reduce premium costs, the continued proliferation of tiered copayment benefits can be expected. |
format | Online Article Text |
id | pubmed-10437939 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2006 |
publisher | Academy of Managed Care Pharmacy |
record_format | MEDLINE/PubMed |
spelling | pubmed-104379392023-08-21 Measuring Value in the Treatment of Symptoms of Allergic Rhinitis With Nasal Steroids Curtiss, Frederic R. J Manag Care Pharm Editorials Patients' willingness to pay (WTP) is a subject of interest, particularly in these times of consumer-directed health care and benefit designs that involve multiple copayment tiers. Since tiered copayment products have been found to reduce premium costs, the continued proliferation of tiered copayment benefits can be expected. Academy of Managed Care Pharmacy 2006-03 /pmc/articles/PMC10437939/ /pubmed/16515376 http://dx.doi.org/10.18553/jmcp.2006.12.2.168 Text en Copyright © 2006, Academy of Managed Care Pharmacy. All rights reserved. https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Editorials Curtiss, Frederic R. Measuring Value in the Treatment of Symptoms of Allergic Rhinitis With Nasal Steroids |
title | Measuring Value in the Treatment of Symptoms of Allergic Rhinitis With Nasal Steroids |
title_full | Measuring Value in the Treatment of Symptoms of Allergic Rhinitis With Nasal Steroids |
title_fullStr | Measuring Value in the Treatment of Symptoms of Allergic Rhinitis With Nasal Steroids |
title_full_unstemmed | Measuring Value in the Treatment of Symptoms of Allergic Rhinitis With Nasal Steroids |
title_short | Measuring Value in the Treatment of Symptoms of Allergic Rhinitis With Nasal Steroids |
title_sort | measuring value in the treatment of symptoms of allergic rhinitis with nasal steroids |
topic | Editorials |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437939/ https://www.ncbi.nlm.nih.gov/pubmed/16515376 http://dx.doi.org/10.18553/jmcp.2006.12.2.168 |
work_keys_str_mv | AT curtissfredericr measuringvalueinthetreatmentofsymptomsofallergicrhinitiswithnasalsteroids |